Journal Impact
Enter journal title, issn or abbr in this box to search

Cancer Biotherapy and Radiopharmaceuticals

Journal Abbreviation: CANCER BIOTHER RADIO
Journal ISSN: 1084-9785

About Cancer Biotherapy and Radiopharmaceuticals

    Cancer Biotherapy and Radiopharmaceuticals is a peer-reviewed journal covering cutting-edge biotherapy and innovative investigations of methods to improve cancer therapy. Includes more selective delivery of drugs, biologicals, radiopharmaceuticals, or other agents, and advances in delivery instrumentation and technology, with the aim of increasing efficacy of therapy and/or decreasing toxicity or improving convenience of therapy.<br/><br/>Topics include:<br/>Pre-targeted cancer therapy<br/>Clinical trials in cancer research<br/>Antibody therapy and imaging<br/>Tumor cell vaccines<br/>Radioimmunotherapy<br/>T-cell therapy<br/>Molecular targeted therapy and imaging<br/>Drug resistance
Year Impact Factor (IF) Total Articles Total Cites
2022 (2023 update) 3.4 - 2857
2021 3.632 - 3008
2020 3.099 224 2281
2019 2.314 84 1707
2018 1.894 57 1562
2017 1.682 45 1619
2016 1.689 49 1567
2015 1.715 58 1440
2014 1.778 61 1470
2013 1.381 97 1336
2012 1.738 92 1292
2011 1.787 84 1261
2010 1.873 88 1186

You may also be interested in the following journals

<< Cancer Biomarkers
Cancer Causes & Control >>

Top Journals in other

Journal Impact